Remedium Capital Partners as of March 31, 2026
Portfolio Holdings for Remedium Capital Partners
Remedium Capital Partners holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aeglea Biotherapeutics (SYRE) | 30.1 | $96M | 1.9M | 50.44 | |
| Oruka Therapeutics (ORKA) | 29.0 | $93M | 1.9M | 49.05 | |
| Galecto (DMRA) | 16.6 | $53M | 2.0M | 25.90 | |
| Apogee Therapeutics (APGE) | 15.4 | $49M | 584k | 84.17 | |
| Jade Biosciences (JBIO) | 6.9 | $22M | 1.6M | 14.05 | |
| Crescent Biopharma | 2.1 | $6.6M | 361k | 18.37 |
